Position in AZN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$2,392,224,162
New position
Shares Held
12,129,724
first reported quarter
Ownership
0.782%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 53.63417172558914.ToString("F0")%
Shared 0.12366316001913977.ToString("F0")%
None 46.24216511439172.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $16,087,469,920 across 16 Drug Manufacturers - General names. AZN ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,435,647 | $3,528,649,542 | |
| 2 | LLY |
ELI LILLY & Co
|
3,547,772 | $3,263,134,246 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
12,129,724 | $2,392,224,162 | |
| 4 | ABBV |
AbbVie Inc.
|
9,531,362 | $2,072,975,912 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,540,774 | $1,508,529,698 | |
| 6 | PFE |
Pfizer Inc
|
31,428,987 | $882,525,946 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,222,328 | $867,205,844 | |
| 8 | AMGN |
Amgen Inc
|
2,255,759 | $793,688,795 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,392,224,162 | 12,129,724 | Shares | Defined | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||